These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 26813367)

  • 1. [Clinical features of non-alcoholic fatty liver disease and its relationship with serum C-peptide levels in patients with latent autoimmune diabetes in adults].
    Chen M; Li T; Zhang R; Li L; Lu J; Bao Y; Jia W
    Zhonghua Yi Xue Za Zhi; 2015 Nov; 95(44):3575-8. PubMed ID: 26813367
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The relationship between non-alcoholic fatty liver disease and metabolic syndrome in patients with latent autoimmune diabetes in adults].
    Yu TP; Zhao CC; Chen MY; Lu JX; Li LX; Jia WP
    Zhonghua Yi Xue Za Zhi; 2018 Aug; 98(30):2398-2402. PubMed ID: 30138983
    [No Abstract]   [Full Text] [Related]  

  • 3. Serum fetuin-B level is an independent marker for nonalcoholic fatty liver disease in patients with type 2 diabetes.
    El-Ashmawy HM; Ahmed AM
    Eur J Gastroenterol Hepatol; 2019 Jul; 31(7):859-864. PubMed ID: 30601337
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Relationship Between Liver Enzymes and Insulin Resistance in Type 2 Diabetes Patients with Nonalcoholic Fatty Liver Disease.
    Sheng X; Che H; Ji Q; Yang F; Lv J; Wang Y; Xian H; Wang L
    Horm Metab Res; 2018 May; 50(5):397-402. PubMed ID: 29723898
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sex influenced association of directly measured insulin sensitivity and serum transaminase levels: Why alanine aminotransferase only predicts cardiovascular risk in men?
    Buday B; Pach PF; Literati-Nagy B; Vitai M; Kovacs G; Vecsei Z; Koranyi L; Lengyel C
    Cardiovasc Diabetol; 2015 May; 14():55. PubMed ID: 25986611
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insulin resistance and metabolic syndrome in patients with NAFLD but without diabetes: effect of a 6 month regime intervention.
    Cankurtaran M; Tayfur O; Yavuz BB; Geyik S; Akhan O; Arslan S
    Acta Gastroenterol Belg; 2007; 70(3):253-9. PubMed ID: 18074733
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum retinol binding protein 4 is negatively related to beta cell function in Chinese women with non-alcoholic fatty liver disease: a cross-sectional study.
    Yan H; Chang X; Xia M; Bian H; Zhang L; Lin H; Chen G; Zeng M; Gao X
    Lipids Health Dis; 2013 Oct; 12():157. PubMed ID: 24160775
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Correlation between intrahepatic triglyceride content quantified by proton magnetic resonance spectroscopy and glucose metabolism].
    Long XX; Liu D; Wu L; Qian LL; Fang QC; Li HT; Jia WP
    Zhonghua Nei Ke Za Zhi; 2021 Dec; 60(12):1157-1164. PubMed ID: 34856688
    [No Abstract]   [Full Text] [Related]  

  • 9. Non-alcoholic fatty liver disease is closely associated with sub-clinical inflammation: a case-control study on Asian Indians in North India.
    Nigam P; Bhatt SP; Misra A; Vaidya M; Dasgupta J; Chadha DS
    PLoS One; 2013; 8(1):e49286. PubMed ID: 23326306
    [TBL] [Abstract][Full Text] [Related]  

  • 10. C-peptide as a key risk factor for non-alcoholic fatty liver disease in the United States population.
    Atsawarungruangkit A; Chenbhanich J; Dickstein G
    World J Gastroenterol; 2018 Aug; 24(32):3663-3670. PubMed ID: 30166861
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dulaglutide decreases plasma aminotransferases in people with Type 2 diabetes in a pattern consistent with liver fat reduction: a post hoc analysis of the AWARD programme.
    Cusi K; Sattar N; García-Pérez LE; Pavo I; Yu M; Robertson KE; Karanikas CA; Haupt A
    Diabet Med; 2018 Oct; 35(10):1434-1439. PubMed ID: 29869810
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Correlation analysis of gut microbiota and biochemical indexes in patients with non-alcoholic fatty liver disease].
    Ren SM; Mei L; Huang H; Cao SF; Zhao RH; Zheng PY
    Zhonghua Gan Zang Bing Za Zhi; 2019 May; 27(5):369-375. PubMed ID: 31177662
    [No Abstract]   [Full Text] [Related]  

  • 13. Insulin resistance is independently associated with liver aminotransferases in diabetic patients without ultrasound signs of nonalcoholic fatty liver disease.
    Esteghamati A; Noshad S; Khalilzadeh O; Khalili M; Zandieh A; Nakhjavani M
    Metab Syndr Relat Disord; 2011 Apr; 9(2):111-7. PubMed ID: 21091060
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased risks of different grades of non-alcoholic fatty liver disease in prediabetic subjects with impaired fasting glucose and glucose tolerance, including the isolated glycosylated hemoglobin levels of 5.7-6.4% in a Chinese population.
    Li CH; Chou YT; Shen WC; Lu FH; Yang YC; Wu JS; Chang CJ
    J Diabetes Investig; 2020 Sep; 11(5):1336-1343. PubMed ID: 32270583
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anthropometric measures of visceral and subcutaneous fat are important in the determination of metabolic dysregulation in boys and girls at risk for nonalcoholic fatty liver disease.
    Mager DR; Yap J; Rodriguez-Dimitrescu C; Mazurak V; Ball G; Gilmour S
    Nutr Clin Pract; 2013 Feb; 28(1):101-11. PubMed ID: 23042833
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of hepatic insulin resistance indexes to nonalcoholic fatty liver disease and related biomarkers.
    Sesti G; Fiorentino TV; Hribal ML; Sciacqua A; Perticone F
    Nutr Metab Cardiovasc Dis; 2013 Dec; 23(12):1182-7. PubMed ID: 23419734
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Advanced glycation end product: A potential biomarker for risk stratification of non-alcoholic fatty liver disease in ELSA-Brasil study.
    Pereira ENGDS; Paula DP; de Araujo BP; da Fonseca MJM; Diniz MFHS; Daliry A; Griep RH
    World J Gastroenterol; 2021 Aug; 27(29):4913-4928. PubMed ID: 34447235
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of a fruit-rich diet on liver biomarkers, insulin resistance, and lipid profile in patients with non-alcoholic fatty liver disease: a randomized clinical trial.
    Alami F; Alizadeh M; Shateri K
    Scand J Gastroenterol; 2022 Oct; 57(10):1238-1249. PubMed ID: 35710164
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The value of neck circumference (NC) as a predictor of non-alcoholic fatty liver disease (NAFLD).
    Hu Y; Chen J; Yang L; Chen P; Li J; Chen L; Chen J; Huang X; Zhang Y; Bu S; Huang Q
    J Clin Transl Endocrinol; 2014 Dec; 1(4):133-139. PubMed ID: 29159094
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Benefits of exenatide on obesity and non-alcoholic fatty liver disease with elevated liver enzymes in patients with type 2 diabetes.
    Shao N; Kuang HY; Hao M; Gao XY; Lin WJ; Zou W
    Diabetes Metab Res Rev; 2014 Sep; 30(6):521-9. PubMed ID: 24823873
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.